Sugi Predict

Sugi Predict / Compounds / SCHEMBL636014

SCHEMBL636014

SCHEMBL636014

O=C1Cc2ccc3ccccc3c2C(=O)N1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TDP2 O95551 12/20 0.51
▸ CASP3 P42574 1/20 0.49
▸ CASP7 P55210 1/20 0.49
▸ CASP9 P55211 1/20 0.49
▸ CASP6 P55212 1/20 0.49
▸ CASP8 Q14790 1/20 0.49
▸ MAP3K14 Q99558 1/20 0.49
▸ AHR P35869 1/20 0.43
▸ PDK2 Q15119 1/20 0.43
▸ CDK4 P11802 2/20 0.40
▸ CCND1 P24385 2/20 0.40
▸ CCNB2 O95067 1/20 0.40
▸ CCNE2 O96020 1/20 0.40
▸ PRKCG P05129 1/20 0.40
▸ PRKCB P05771 1/20 0.40
▸ CDK1 P06493 1/20 0.40
▸ CCNB1 P14635 1/20 0.40
▸ PRKCA P17252 1/20 0.40
▸ CCNE1 P24864 1/20 0.40
▸ CDK2 P24941 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2905322 0.79 AHR (0.49) TDP2CASP3CASP7CASP9CASP6
SCHEMBL22904285 0.77 TDP2 (0.50) TDP2CASP3CASP7CASP9CASP6
SCHEMBL5380849 0.76 TDP2 (0.49) TDP2CASP3CASP7CASP9CASP6
SCHEMBL6987200 0.76 DNMT1 (0.46) ANPEPDNMT1
SCHEMBL31069613 0.75 AURKA (0.47) CDK4CCND1PRKCGPRKCBPRKCA
SCHEMBL29716676 0.75 TSHR (0.52) ANPEPDNMT1
SCHEMBL868639 0.75 TSHR (0.52) ANPEPDNMT1
SCHEMBL30635134 0.73 TDP2 (0.46) TDP2CASP3CASP7CASP9CASP6
SCHEMBL21385140 0.73 TSHR (0.50) ANPEPDNMT1
SCHEMBL1501866 0.73 DNMT1 (0.47) ANPEPDNMT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 283 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118812431-A Preparation method and application of hydroxyl radical-responsive hydrogen sulfide donor 重庆理工大学 2024-10-22 — — CN claimed
CN-118772057-A Preparation method and application of nitroreductase-responsive hydrogen sulfide donor 重庆理工大学 2024-10-15 — — CN claimed
CN-117924339-A Hydrogen sulfide donor and preparation method and application thereof 重庆理工大学 2024-04-26 — — CN claimed
CN-117551076-A Benzisoquinoline-1, 3 (2H) -dione derivatives, preparation method and application thereof 河南应用技术职业学院 2024-02-13 — — CN claimed
CN-117229520-A Metal-organic framework double-detection fluorescent sensing material, preparation method and application thereof 山东师范大学 2023-12-15 — — CN claimed
CN-109988312-B Polyamide acid ester, preparation method, negative polyimide composition and application 深圳先进技术研究院 2023-04-11 — — CN claimed
CN-112321827-B Application of compound as polyimide curing accelerator, polyimide precursor and preparation method and application thereof 中国科学院深圳先进技术研究院 2023-03-14 — — CN claimed
CN-111440563-A Curing agent and urea-formaldehyde resin composition containing same 杭州临安迪恩化工有限公司 2020-07-24 — — CN claimed
US-20160106743-A1 TOPOISOMERASE II POISONS AND METHODS OF MAKING AND USING SAME THE UNIVERSITY OF ROCHESTER (US) 2016-04-21 — — US claimed
US-20090181971-A1 Inhibitors of Histone Deacetylase METHYLGENE INC. 2009-07-16 — — US claimed
EP-1524262-A1 Inhibitors of histone deacetylase Methylgene, Inc. (CA) 2005-04-20 — — EP claimed
EP-1042315-B1 CYCLIC IMIDE-SUBSTITUTED PYRIDYLALKANE, ALKENE, AND ALKINE CARBOXAMIDES USEFUL AS CYTOSTATIC AND IMMUNOSUPPRESSIVE AGENTS KLINGE CO CHEM PHARM FAB (DE) 2004-04-14 — — EP claimed
EP-1280764-A2 INHIBITORS OF HISTONE DEACETYLASE Methylgene, Inc. (CA) 2003-02-05 — — EP claimed
US-20020115826-A1 Inhibitors of histone deacetylase 92229129 QUEBEC INC. (CA) 2002-08-22 — — US claimed
WO-2001070675-A2 INHIBITORS OF HISTONE DEACETYLASE METHYLGENE, INC. (CA) 2001-09-27 — — WO claimed
US-5874444-A CONTROLLING CELL AGING GERON CORPORATION (US) 1999-02-23 — — US claimed
US-5756650-A COMPOSITION COMPRISING POLYAMIC ACID, CURE ACCELERATOR SELECTED FROM GROUP CONSISTING OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND, AMINO ACID COMPOUND, AROMATIC COMPOUND HAVING TWO OR MORE HYDROXYL GROUPS KABUSHIKI KAISHA TOSHIBA (JP) 1998-05-26 — — US claimed
US-12624118-B2 Trispecific binding molecules against BCMA and uses thereof NOVARTIS AG (CH) 2026-05-12 — — US disclosed
WO-1993009123-A1 HETEROCYCLIC AMINO-BORANES BORON BIOLOGICALS, INC. (US) 1993-05-13 — — WO disclosed
US-5183821-A Administering anticarcinogenic agents LABORATORIES KNOLL, S.A. (ES) 1993-02-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020115826-A1 Inhibitors of histone deacetylase HDAC1, HDAC5, HDAC3 TDP2 1186/4885CASP3 1184/4885CASP7 1938/4885
US-12624118-B2 Trispecific binding molecules against BCMA and uses thereof CD2, CD40, CD22 TDP2 3394/4885CASP3 3959/4885CASP7 4546/4885
US-20160106743-A1 TOPOISOMERASE II POISONS AND METHODS OF MAKING AND USING SAME TOP2A, TOP2B, TOP1 TDP2 5/4885CASP3 47/4885CASP7 33/4885
US-20090181971-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC3 TDP2 1186/4885CASP3 1184/4885CASP7 1938/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.